Inhibition of eosinophil chemotaxis by chronic blockade of nitric oxide biosynthesis

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 201-207

  Ferreira, Heloisa H A ^a   Medeiros, Marta V ^a   Lima, Carmen S P ^a   Flores, Carlos A ^b   Sannomiya, Paulina ^c   Antunes, Edson ^a   De Nucci, Gilberto ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

cGMP; Eosinophil chemotaxis; N( ) Nitro L arginine methyl ester; Nitrix oxide (NO); Pleurisy

Indexed keywords

BRADYKININ; CARRAGEENAN; CYCLIC GMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; EOSINOPHIL; INTRAPLEURAL DRUG ADMINISTRATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLEURISY; PRIORITY JOURNAL; RAT;

EID: 0030605980     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00379-2     Document Type: Article

References (51)

1. Anderson, R., A. Glover, H.J. Koornhof and A.R. Rabson, 1986, In vitro stimulation of neutrophil motility by levamisole: maintenance of cGMP levels in chemotactically stimulated levamisole-treated neutrophils, J. Immunol. 117, 428.
2. Bath, P.M.W., D.G. Hassall, A.-M. Gladwin, R.M.J. Palmer and J.F. Martin, 1991, Nitric oxide and prostacyclin: divergence of inhibitory effects of monocyte chemotaxis and adhesion to endothelium in vitro, Arter. Thromb. 11, 254.
3. Beauvais, F., L. Michel and L. Dubertret, 1995, The nitric oxide, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils. FEBS Lett. 361, 229.
4. Belenky, S.N., R.A. Robbins, S.I. Rennard, G.L. Gossman, K.J. Nelson and I. Rubinstein, 1993a, Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro, J. Lab. Clin. Med. 122, 388.
5. Belenky, S.N., R.A. Robbins and I. Rubintein, 1993b, Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro, J. Leuk. Biol. 498, 498.
6. Bolotina, V.M., S. Najibi, J.J. Palacino, P.J. Pagano and R.A. Cohen, 1994, Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368, 850.
7. Bozza, P.T., H.C. Castro-Faria-Neto, M.A. Martins, A.P. Larangeira, J.E. Perales, P.M.R. Silva and R.S.B. Cordeiro, 1993, Pharmacological modulation of lipopolysaccharide-induced pleural eosinophilia in the rat: a role of newly generated protein, Eur. J. Pharmacol. 248, 41.
8. Bozza, P.T., H.C. Castro-Faria-Neto, C. Penido, A.P. Larangeira, M. Graças, M.O. Henriques, P.M.R. Silva, M.A. Martins, R.R. Santos and R.S.B. Cordeiro, 1994. Requirement for lymphocytes and resident macrophages in LPS-induced pleural eosinophil accumulation. J. Leuk. Biol. 56, 151.
9. Brune, B. and E.G. Lapetina, 1989, Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents, J. Biochem. Chem. 264, 8455.
10. Bruynzeel, P.L.B., P.T.M. Kok, M.L. Hamelink, A.M. Kijne and J. Verjagen, 1987. Platelet-activating factor induces leukotriene-C4 synthesis by purified human eosinophils, Prostaglandins 34, 205.
11. 4 in human eosinophils stimulated by unopsonized zymosan and by calcium ionophore A23187: the effect of nedocromil sodium, J. Allergy Clin. Immunol. 85, 26.
12. Clancy, R.M., J. Leszczynska-Piziak and S.B. Abramson, 1994, Nitric oxide stimulates the ADP-ribosylation of actin in human neutrophils, Biochem. Biophys. Res. Commun. 31, 847.
13. Cunha, F.Q., D.W. Moss, L.M.C.C. Leal, S. Moncada and F.Y. Liew, 1993, Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway, Immunology 78, 563.
14. Damas, J. and P. Prunescu, 1993. Presence of immunoreactive platelet-activating factor in peritoneal exudate induced by zymosan in rats. Arch. Int. Pharmacodyn. Ther. 322, 115.
15. Davenpeck, K.L., T.W. Gauthier and A.M. Lefer, 1994, Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation, Gastroenterology 107, 1050.
16. Dechatelet, L.R., M.R. Shirley, L.C. McPhail, C.C. Hunely, H.B. Muss and D.A. Bass, 1977, Oxidative metabolism of human eosinophils, Blood 50, 525.
17. 2 from bovine aortic endothelial cells is coupled. Proc. Natl. Acad. Sci. USA 85, 2334.
18. Etienne, A., C. Soulard, F. Thonier and P. Braquet, 1989, Modulation by drugs of eosinophil recruitment induced by immune challenge in the rat. Possible roles of interleukin 5 and platelet-activating factor, Int. Arch. Allergy Appl. Immunol. 88, 216.
19. Gauthier, T.W., K.L. Davenpeck and A.M. Lefer, 1994, Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am. J. Physiol. Gastrointest. Liver Physiol. 267, 30.
20. Giraldelo, C.M.M., A. Zappellini, M.N. Muscará, I.M.S. De Luca, S. Hyslop, G. Cirino, R. Zatz, G. De Nucci and E. Antunes, 1994, Effect of arginine analogues on rat hind paw eodema and mast cell activation in vitro, Eur. J. Pharmacol. 257, 87.
21. Gleich, G.J. and C.R. Adolphson, 1986, The eosinophil leukocyte: structure and function, Adv. Immunol. 39, 177.
22. Hughes, S.R., T.J. Williams and S.D. Brain, 1990, Evidence that endogeneous nitric oxide modulates oedema formation induced by substance P, Eur. J. Pharmacol. 191, 481.
23. Ialenti, A., A. Ianaro, S. Moncada and M. Di Rosa, 1992, Modulation of acute inflammation by endogenous nitric oxide, Eur. J. Pharmacol. 211, 177.
24. Ignarro, L.J., G.M. Buga, K.S. Wood, R.E. Byrns and G. Chaudhuri, 1987, Endothelium-derived relaxing factor produce and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 84, 9265.
25. Kanofsky, J.R., H. Hoogland, R. Wever and S.J. Weiss, 1988, Singlet oxygen production by human eosinophils, J. Biol. Chem. 263, 9692.
26. G-monomethyl-L-arginine: a role for cyclic GMP. Blood 74, 1885.
27. Kroegel, C. and H. Matthya, 1993, Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclooxygenase metabolites in human blood eosinophils from asthmatics, Immunology 78, 279.
28. 1 and nitric oxide donors as potentiators of plasma exudation in the rabbit skin in vivo, Prost. Leuk. Essential Fatty Acids 52, 399.
29. Marietta, M.A., P.S. Yoon, R. Iyengar, C.D. Leaf and J.S. Wishnok, 1988, Macrophage oxidation of L-arginine to nitrite and nitrate. Nitric oxide is an intermediate. Biochemistry 27, 8706.
30. Martins, M.A., P.M.R. Silva, H.C. Faria-Neto, P.T. Bozza, P.M.F.L. Dias, M.C.R. Lima, R.S.B. Cordeiro and B.B. Vargaftig, B.B., 1989. Pharmacological modulation of Paf-induced pleurisy and its role in inflammation by zymozan, Br. J. Pharmacol. 96, 363.
31. Medeiros, M.V., I.M. Binhara, H. Moreno Jr, G. De Nucci and E. Artunes, 1995, Effect of chronic nitric oxide inhibition on the inflammatory responses induced by carrageenin in rats. Eur. J. Pharmacol. 285, 109.
32. Mellion, B.T., L.L. Ignarro, E.M. Ohlstein, E.G. Ponte-corvo, A.L. Hyman and P.J. Kadowitz, 1980, Evidence for the inhibitory role of guanosine 3′:5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 57, 946.
33. Moilanen, E., P. Vuorinen, H. Kankaanranta, T. Metsa-Ketela and H. Vapaatalo, 1993, Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions, Br. J. Pharmacol. 109, 852.
34. Moqbel, R., Q. Hamid, S. Ying, J. Barkans, A. Hartnell, A. Tsicopoulos, A.J. Wardlaw and A. Barry Kay, 1991, Expression of mRNA and immunmoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils, J. Exp. Med. 174, 749.
35. Munoz-Fernandez. M.A., M.A. Fernandez and M. Fresno, 1992, Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism, Immunol Lett. 33, 35.
36. Palmer, R.M.J., A.G. Ferrige and S. Moncada, 1987, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327, 524.
37. Pasquale, C.P., M.A. Martins, P.T. Bozza, P.M.R. Silva, H.C. Faria-Neto, A.L.A. Pires and R.S.B. Cordeiro, 1991, Bradykinin induces eosinophil accumulation in the rat pleural cavity, Int. Arch. Allergy Appl. Immunol. 95, 244.
38. Petray, P., M.E. Rottenberg, S. Grinstein and A. Om, 1994, Release of nitric oxide during the experimental infection with Trypanosoma cruzi, Parasite Immunol. 16, 193.
39. Paul, W., G.J. Douglas, L. Lawrence, A.M. Khawaja, A.C. Perez, M. Scachter and C.P. Page, 1994, Cutaneous permeability responses to bradykinin and histamine in the guinea-pig: possible differences in their mechanism of action, Br. J. Pharmacol. 111, 159.
40. Ribeiro, M.O., E. Antunes, G. De Nucci, S.M. Lovisolo and R. Zatz, 1992, Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20, 298.
41. Richards, K.I. and J.M. McCullough, 1984, A modified microchamber method for chemotaxis and chemokinesis, Immunol. Commun. 13, 49.
42. Rimele, T.J., Sturm and L.M. Adams, 1988, Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J. Pharmacol. Exp. Ther. 245, 102.
43. Salvemini, D., G. De Nucci, R. Gryglewski and J.R. Vane, 1989, Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor, Proc. Natl. Acad. Sci. USA 86, 6328.
44. Sandler, J.A., J.I. Gallin and M. Vaughn, 1975, Effects of serotonin, carbamyl-choline, and ascorbic acid on leukocyte cyclic GMP and chemotaxis, J. Cell Biol. 67, 480.
45. 4. FEBS Lett. 244, 357.
46. Schroder, H., P. Ney, I. Woditsch and K. Schror, 1990, Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes. Eur. J. Pharmacol. 182, 211.
47. Stenger, S., H. Thuring, M. Rollinghoff and C. Bogdan, 1994, Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major, J. Exp. Med. 180, 783.
48. Teixeira, M.M., T.J. Williams and P.G. Hellewell, 1993, Role of prostaglandins and nitric oxide in acute inflammatory reactions in guinea-pig skin, Br. J. Pharmacol. 110, 1515.
49. Teixeira, M.M., T.J. Williams and P.G. Hellewell, 1995, Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo, Trends Pharmacol. Sci. 16, 418.
50. Vadas, M.A. J.R. David, A. Butterworth, N.T. Pisani and T.A. Siongok, 1979, A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni, J. Immunol. 122, 1228.
51. Zatz, R., 1990, A low-cost tail-cuff method for the estimation of mean arterial pressure in conscious rats, Lab. Anim. Sci. 42, 198.